<br><br><div id="ymail_android_signature"><a id="ymail_android_signature_link" href="https://mail.onelink.me/107872968?pid=nativeplacement&c=US_Acquisition_YMktg_315_SearchOrgConquer_EmailSignature&af_sub1=Acquisition&af_sub2=US_YMktg&af_sub3=&af_sub4=100002039&af_sub5=C01_Email_Static_&af_ios_store_cpp=0c38e4b0-a27e-40f9-a211-f4e2de32ab91&af_android_url=https://play.google.com/store/apps/details?id=com.yahoo.mobile.client.android.mail&listing=search_organize_conquer">Sent from Rogers Yahoo Mail on Android</a></div> <br> <blockquote style="margin: 0 0 20px 0;"> <div style="padding: 10px 0 0 20px; margin: 10px 0 0 0; border-left: 1px solid #6D00F6;"> <div style="font-family:Roboto, sans-serif; color:#6D00F6;">  <div><br></div>  </div>  <div id="yiv9970944211"><style><!--

#yiv9970944211 filtered {}
#yiv9970944211 filtered {}
#yiv9970944211 filtered {}
#yiv9970944211 filtered {}

#yiv9970944211 p.yiv9970944211MsoNormal, #yiv9970944211 li.yiv9970944211MsoNormal, #yiv9970944211 div.yiv9970944211MsoNormal
        {margin:0in;font-size:11.0pt;font-family:"Calibri", sans-serif;}
#yiv9970944211 a:link, #yiv9970944211 span.yiv9970944211MsoHyperlink
        {color:#0563C1;text-decoration:underline;}
#yiv9970944211 span.yiv9970944211xn-person
        {}
#yiv9970944211 span.yiv9970944211EmailStyle20
        {font-family:"Calibri", sans-serif;color:windowtext;}
#yiv9970944211 .yiv9970944211MsoChpDefault
        {font-size:10.0pt;}
#yiv9970944211 filtered {}
#yiv9970944211 div.yiv9970944211WordSection1
        {}
--></style><div><div class="yiv9970944211WordSection1"><p class="yiv9970944211MsoNormal"><span style="font-size:10.0pt;font-family:"Verdana", sans-serif;">Please distribute.</span></p><p class="yiv9970944211MsoNormal"><span style="font-size:10.0pt;font-family:"Verdana", sans-serif;">  </span></p><p class="yiv9970944211MsoNormal"><span style="font-size:10.0pt;font-family:"Verdana", sans-serif;">On <b>Feb 11^th</b>, your members are all invited to participate in a joint Brampton/Oakville-Mississauga zoom presentation on “<b>technological advanced in prostate cancer screening</b>” (see Zoom link information below).</span></p><p class="yiv9970944211MsoNormal"><span style="font-size:10.0pt;font-family:"Verdana", sans-serif;">  </span></p><p style="margin-bottom:10.0pt;text-align:justify;" class="yiv9970944211MsoNormal"><b><span style="font-size:10.0pt;font-family:"Verdana", sans-serif;">Title: <br></span></b><span style="font-size:10.0pt;font-family:"Verdana", sans-serif;">Technological Advances in Prostate Cancer Screening</span></p><p style="margin-bottom:10.0pt;text-align:justify;" class="yiv9970944211MsoNormal"><b><span style="font-size:10.0pt;font-family:"Verdana", sans-serif;">Objectives: </span></b><span style="font-size:10.0pt;font-family:"Verdana", sans-serif;"></span></p><p class="yiv9970944211MsoNormal"><span style="font-size:10.0pt;font-family:"Verdana", sans-serif;">1. Understand the need for improvement of current prostate cancer screening guidelines in Canada</span></p><p class="yiv9970944211MsoNormal"><span style="font-size:10.0pt;font-family:"Verdana", sans-serif;">2. Understand the necessity & benefit of adjunctive testing strategies in prostate cancer screening </span></p><p class="yiv9970944211MsoNormal"><span style="font-size:10.0pt;font-family:"Verdana", sans-serif;">3. Increase awareness & understanding of ClarityDX Prostate</span></p><p class="yiv9970944211MsoNormal"><span style="font-size:10.0pt;font-family:"Verdana", sans-serif;">  </span></p><p class="yiv9970944211MsoNormal"><span style="font-size:10.0pt;font-family:"Verdana", sans-serif;">PSA is the only prostate cancer biomarker routinely used by urologists. However, PSA alone does not distinguish well between cancer and benign prostatic hyperplasia or between indolent and aggressive cancers, potentially leading to overtreatment, especially unnecessary biopsies. </span></p><p class="yiv9970944211MsoNormal"><span style="font-size:10.0pt;font-family:"Verdana", sans-serif;">  </span></p><p class="yiv9970944211MsoNormal"><span style="font-size:10.0pt;font-family:"Verdana", sans-serif;">ClarityDX Prostate uses clinical and blood-based biomarkers to determine a patient’s risk of having clinically significant prostate cancer</span></p><p class="yiv9970944211MsoNormal"><span style="font-size:10.0pt;font-family:"Verdana", sans-serif;">ClarityDX Prostate is a decision support tool that accurately predicts clinically significant (aggressive) prostate cancer after an abnormal PSA or a suspicion of prostate cancer.  <a rel="nofollow noopener noreferrer" target="_blank" href="https://www.nanosticsdx.com/claritydx-prostate/">https://www.nanosticsdx.com/claritydx-prostate/</a></span></p><p class="yiv9970944211MsoNormal"><span style="font-size:10.0pt;font-family:"Verdana", sans-serif;">  </span></p><p class="yiv9970944211MsoNormal"><span style="font-size:10.0pt;font-family:"Verdana", sans-serif;color:#373737;background:white;">"This study shows that ClarityDX Prostate is accurate at predicting if the patient has grade group 2 and above prostate cancer," said Dr. <span class="yiv9970944211xn-person">Eric Hyndman</span>, Urologist and Chief Medical Officer at Nanostics. "Using this as an adjunctive test after PSA screening will give physicians more information to help decide if their patient should undergo a prostate biopsy or not."</span><span style="font-size:10.0pt;font-family:"Verdana", sans-serif;"></span></p><p class="yiv9970944211MsoNormal"><span style="font-size:10.0pt;font-family:"Verdana", sans-serif;">  </span></p><p class="yiv9970944211MsoNormal"><span style="font-size:10.0pt;font-family:"Verdana", sans-serif;">Time: <b>Feb 11, 2025 07:30 PM Eastern Time</b> (US and Canada)</span></p><p class="yiv9970944211MsoNormal"><span style="font-size:10.0pt;font-family:"Verdana", sans-serif;">       </span></p><p class="yiv9970944211MsoNormal"><span style="font-size:10.0pt;font-family:"Verdana", sans-serif;">Join Zoom Meeting <a rel="nofollow noopener noreferrer" target="_blank" href="https://us02web.zoom.us/j/82819100419?pwd=TFhVUTZBQTNhZVRRSkE0VU9EM0ordz09">https://us02web.zoom.us/j/82819100419?pwd=TFhVUTZBQTNhZVRRSkE0VU9EM0ordz09</a></span></p><p class="yiv9970944211MsoNormal"><span style="font-size:10.0pt;font-family:"Verdana", sans-serif;">  </span></p><p class="yiv9970944211MsoNormal"><span style="font-size:10.0pt;font-family:"Verdana", sans-serif;">Meeting ID: 828 1910 0419; Passcode: 091248</span></p><p class="yiv9970944211MsoNormal"><span style="font-size:10.0pt;font-family:"Verdana", sans-serif;">  </span></p></div></div></div> </div> </blockquote>